E249 - Unintended Effects of FDA Pediatric An...

In this episode, Dr. Andy Cutler speaks with Dr. Tim Wilens about the complex relationship between attention-deficit/hyperactivity disorder (ADHD) and substance use disorders. They discuss how to distinguish ADHD from substance-related cognitive symptoms, determine when co-occurr ...  Show more

Originally released in 2021, this episode features Dr. Thomas Schwartz discussing common mistakes in psychopharmacology and how psychiatric clinicians can recognize and manage them. He explores diagnostic uncertainty, medication dosing, informed consent and monitoring, and ration ...  Show more

Welcome to another special guest episode. In this episode, we are joined by Dr. Christine Yu Moutier, M.D., the acting Chief Medical Officer of the American Foundation for Suicide Prevention. We’ll be discussing important topics around suicide prevention and much more.

...

Our physicians and expert guests will discuss practical strategies, actionable steps and evidence-based resources on how to identify those physicians and patients at-risk for suicide and connect them with the most appropriate care. Our guests include: Daniel Miller, MD, Chief of ...  Show more

Join us for a candid and insightful discussion with two leading experts: Dr. Christina Riachi, a clinical psychologist, and Dr. Fady Maalouf, psychiatrist and Chairperson at AUBMC. They'll demystify the use of psychiatric medications, exploring the pros, cons, and crucial convers ...  Show more

Host: Darryl S. Chutka, M.D.

Guests: Bruce Sutor, M.D. & Megan R. Leloux, Pharm.D., R.Ph., BCPP

Depression is very common both in the U.S. and worldwide. It’s estimated that major depression affects over 8% of American adults, representing over 20 million ind ...